CIK 0001626971
- Non-accelerated filer
- Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464670809
- Phone
- +1 650-900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at an average $12.98 ($12,983)
- 4 Open-market buy Director bought 1,000 shares at an average $12.98 ($12,983)
- 4 Open-market buy Director bought 38,383 shares at an average $12.75 ($489,192)
- 4 Open-market buy Director bought 38,383 shares at an average $12.75 ($489,192)
- 4 Open-market buy Director bought 20,000 shares at an average $12.35 ($247,000)
- 4 Open-market buy Director bought 20,000 shares at an average $12.35 ($247,000)
- 4 Open-market buy Director bought 50,000 shares at an average $12.96 ($648,100)
- 4 Open-market buy Director bought 50,000 shares at an average $12.96 ($648,100)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 4,716 shares at $13.09 ($61,732)
Page 11 of 13 · 252 filings